SARS-CoV-2 vaccines - the biggest medical research project of the 21st century
- PMID: 34049261
- PMCID: PMC8096205
- DOI: 10.1016/j.coviro.2021.04.008
SARS-CoV-2 vaccines - the biggest medical research project of the 21st century
Abstract
SARS-CoV-2 has been detected in more than 141 million people and caused more than 3 million deaths worldwide. To reduce the additional loss of millions of lives until natural immunity is reached, researchers have focused on the only known method to stop the COVID-19 pandemic: vaccines. The pandemic has propelled high-speed vaccine development, some based on novel technology previously not utilized in the vaccine field. The new technology opens new possibilities and comes with challenges because the long-term performance of the new platforms is unknown. Here we review the current leading vaccine candidates against COVID-19 and outline the advantages and disadvantages as well as the unknowns of each candidate.
Copyright © 2021. Published by Elsevier B.V.
Similar articles
-
The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trial.Emerg Microbes Infect. 2024 Dec;13(1):2320913. doi: 10.1080/22221751.2024.2320913. Epub 2024 Feb 29. Emerg Microbes Infect. 2024. PMID: 38860446 Free PMC article. Clinical Trial.
-
An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination.Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211021498. doi: 10.1177/10760296211021498. Clin Appl Thromb Hemost. 2021. PMID: 34060379 Free PMC article. Review.
-
SARS-CoV-2 evolution and vaccines: cause for concern?Lancet Respir Med. 2021 Apr;9(4):333-335. doi: 10.1016/S2213-2600(21)00075-8. Epub 2021 Jan 29. Lancet Respir Med. 2021. PMID: 33524316 Free PMC article. No abstract available.
-
Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype.Viruses. 2021 Feb 9;13(2):270. doi: 10.3390/v13020270. Viruses. 2021. PMID: 33572452 Free PMC article. Review.
-
Iran hopes to defeat COVID with home-grown crop of vaccines.Nature. 2021 Aug;596(7873):475. doi: 10.1038/d41586-021-02216-z. Nature. 2021. PMID: 34404947 No abstract available.
Cited by
-
A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model.Viruses. 2022 May 24;14(6):1126. doi: 10.3390/v14061126. Viruses. 2022. PMID: 35746597 Free PMC article.
-
Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.J Eur Acad Dermatol Venereol. 2022 Feb;36(2):172-180. doi: 10.1111/jdv.17744. Epub 2021 Nov 2. J Eur Acad Dermatol Venereol. 2022. PMID: 34661927 Free PMC article. Review.
-
Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants.Viruses. 2022 Nov 17;14(11):2541. doi: 10.3390/v14112541. Viruses. 2022. PMID: 36423150 Free PMC article. Review.
-
Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees.Vaccines (Basel). 2023 Jun 30;11(7):1183. doi: 10.3390/vaccines11071183. Vaccines (Basel). 2023. PMID: 37514999 Free PMC article.
-
Current vaccine strategies against SARS-CoV-2: Promises and challenges.J Allergy Clin Immunol. 2022 Jul;150(1):17-21. doi: 10.1016/j.jaci.2022.05.008. Epub 2022 May 23. J Allergy Clin Immunol. 2022. PMID: 35618046 Free PMC article. Review.
References
-
- 2021. World Health Organization Coronavirus Disease (COVID-19) Dashboard.https://covid19.who.int/ . [Accessed on 26 February 2021]
-
This is the link to the newest information of the WHO on the current cases of Covid- 19 and vaccine information.
-
- Mosby K. In: Immunology for Pharmacy. Flaherty D.K., editor. 2012. Chapter 25 - Vaccine-Preventable Disease.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous